Works matching Axillary lymph node dissection


Results: 2483
    1
    2
    3
    4
    5
    6
    7

    Combined analysis of the MF18‐02/MF18‐03 NEOSENTITURK studies: ypN‐positive disease does not necessitate axillary lymph node dissection in patients with breast cancer with a good response to neoadjuvant chemotherapy as long as radiotherapy is provided

    Published in:
    Cancer (0008543X), 2025, v. 131, n. 1, p. 1, doi. 10.1002/cncr.35610
    By:
    • Muslumanoglu, Mahmut;
    • Cabioglu, Neslihan;
    • Igci, Abdullah;
    • Karanlık, Hasan;
    • Kocer, Havva Belma;
    • Senol, Kazim;
    • Mantoglu, Baris;
    • Tukenmez, Mustafa;
    • Çakmak, Guldeniz Karadeniz;
    • Ozkurt, Enver;
    • Gulcelik, Mehmet Ali;
    • Emiroglu, Selman;
    • Mollavelioglu, Baran;
    • Yildirim, Nilufer;
    • Bademler, Suleyman;
    • Zengel, Baha;
    • Trabulus, Didem Can;
    • Ugurlu, Mustafa Umit;
    • Uras, Cihan;
    • Ilgun, Serkan
    Publication type:
    Article
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17

    Role of Absorbable Polysaccharide Hemostatic Powder in the Prevention of Complications After Axillary Lymph Node Dissection in Breast Cancer Patients: A Multicenter Retrospective Analysis.

    Published in:
    Medicina (1010660X), 2025, v. 61, n. 1, p. 79, doi. 10.3390/medicina61010079
    By:
    • Parisi, Simona;
    • Lucido, Francesco Saverio;
    • Fisone, Francesca;
    • Ruggiero, Roberto;
    • Tolone, Salvatore;
    • Iovino, Francesco;
    • Santoriello, Antonio;
    • Mongardini, Federico Maria;
    • Paolicelli, Maddalena;
    • Docimo, Ludovico;
    • Gambardella, Claudio
    Publication type:
    Article
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28

    The need to tailor the omission of axillary lymph node dissection to patients with good prognosis and sentinel node micro‐metastases.

    Published in:
    Cancer Medicine, 2023, v. 12, n. 4, p. 4023, doi. 10.1002/cam4.5257
    By:
    • Houvenaeghel, Gilles;
    • de Nonneville, Alexandre;
    • Chopin, Nicolas;
    • Classe, Jean‐Marc;
    • Mazouni, Chafika;
    • Chauvet, Marie‐Pierre;
    • Reyal, Fabien;
    • Tunon de Lara, Christine;
    • Jouve, Eva;
    • Rouzier, Roman;
    • Daraï, Emile;
    • Gimbergues, Pierre;
    • Coutant, Charles;
    • Azuar, Anne Sophie;
    • Villet, Richard;
    • Crochet, Patrice;
    • Rua, Sandrine;
    • Bannier, Marie;
    • Cohen, Monique;
    • Boher, Jean‐Marie
    Publication type:
    Article
    29
    30
    31

    Axillary lymph node dissection is not required for breast cancer patients with minimal axillary residual disease after neoadjuvant chemotherapy.

    Published in:
    World Journal of Surgical Oncology, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12957-024-03547-7
    By:
    • Muslumanoglu, Mahmut;
    • Mollavelioglu, Baran;
    • Cabioglu, Neslihan;
    • Emiroglu, Selman;
    • Tukenmez, Mustafa;
    • Karanlık, Hasan;
    • Ozmen, Tolga;
    • Yılmaz, Ravza;
    • Comert, Rana Gunoz;
    • Onder, Semen;
    • Bayram, Aysel;
    • Simsek, Duygu Has;
    • Oflas, Melis;
    • Ibis, Kamuran;
    • Aydıner, Adnan;
    • Ozmen, Vahit;
    • Igci, Abdullah
    Publication type:
    Article
    32
    33
    34
    35
    36
    37

    Axillary Lymph Node Dissection Rates and Prognosis From Phase III Neoadjuvant Systemic Trial Comparing Neoadjuvant Chemotherapy With Neoadjuvant Endocrine Therapy in Pre-Menopausal Patients With Estrogen Receptor-Positive and HER2-Negative, Lymph Node-Positive Breast Cancer

    Published in:
    Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.741120
    By:
    • Gwark, Sungchan;
    • Noh, Woo Chul;
    • Ahn, Sei Hyun;
    • Lee, Eun Sook;
    • Jung, Yongsik;
    • Kim, Lee Su;
    • Han, Wonshik;
    • Nam, Seok Jin;
    • Gong, Gyungyub;
    • Kim, Seon-Ok;
    • Kim, Hee Jeong
    Publication type:
    Article
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50